-
Mashup Score: 2Five Things to Know About Opill, the First FDA-Approved Over-the-Counter Birth Control Pill - 12 day(s) ago
Dr. Colleen Denny, NYU Langone Hospital—Brooklyn’s director of family planning, discusses Opill, the first FDA-approved over-the-counter birth control pill.
Source: nyulangone.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 19Brain Mechanism Found to Determine Which Memories Last - 1 month(s) ago
NYU Langone researchers say their work shows how the mammalian brain “decides” which memories to make permanent. Learn more.
Source: nyulangone.orgCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 16
NYU Langone study offers the first direct evidence that seizures may be responsible for some sudden deaths in children. Learn more.
Source: nyulangone.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 2Perlmutter Cancer Center Radiation Oncologists Perform Same-Day Spinal Radiosurgery - 6 month(s) ago
Radiation oncologists performed same-day spinal radiosurgery—a first for NYU Langone’s Perlmutter Cancer Center. Learn more.
Source: nyulangone.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Perlmutter Cancer Center at NYU Langone Lake Success Hematology Oncology provides services for people with cancer and blood disorders. Learn more.
Source: nyulangone.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Robert I. Grossman, MD - 2 year(s) ago
Dr. Robert I. Grossman is dean and CEO of NYU Langone Health. Read more.
Source: nyulangone.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 48Visiting Hours - 3 year(s) ago
Please review the current visitor policies for NYU Langone’s inpatient locations and doctor’s offices. Learn more.
Source: nyulangone.orgCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Cancer Genetic Counseling & Testing - 4 year(s) ago
Genetic counselors at Perlmutter Cancer Center’s High-Risk Cancer Genetics Program assess risk and provide genetic counseling and testing. Learn more.
Source: nyulangone.orgCategories: Healthcare Professionals, Latest HeadlinesTweet
Read this article from @nyulangone on the #Opill, a new progestin-only pill not associated with the risk of #bloodclots seen with traditional oral contraceptives, which contain estrogen. We'll discuss during our next PEP Talk on 5/14! https://t.co/j49smFzqAY #stoptheclot https://t.co/WOH5rljIrJ